Moderna announces new supply contract with the u.s. government for an initial 66 million doses of a moderna bivalent covid-19 booster vaccine with options for u.s. government to purchase up to an additional 234 million doses

New u.s. government contract includes an award up to $1.74 billion for 66 million doses to be delivered in 2022; additional options, if exercised, may raise total to 300 million doses cambridge, ma / accesswire / july 29, 2022 / moderna, inc., (nasdaq:mrna) a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced that the u.s. government has secured 66 million doses of a moderna covid-19 vaccine booster candidate, mrna-1273.222, a bivalent booster candidate containing spikevax™ plus the omicron ba.4/5 strain mrna. the contract includes an award of up to $1.74 billion for the manufacture and delivery of 66 million doses of mrna-1273.222, as well as options to purchase up to an additional 234 million doses of covid-19 vaccine booster candidates from moderna.
MRNA Ratings Summary
MRNA Quant Ranking